Tratous Specialist Eye Center, Tishreen University, P.O.Box:25, Latakia, Syria.
Whipps Cross University Hospital, Leytonstone, London, UK.
BMC Ophthalmol. 2022 May 18;22(1):225. doi: 10.1186/s12886-022-02457-0.
To evaluate changes in corneal higher-order aberrations (HOAs) following epithelium-off accelerated corneal cross-linking (A-CXL) and to explore the impact on visual acuity.
In this retrospective case series, 32 eyes of 24 patients with keratoconus (KC) underwent A-CXL. Treatment was delivered at 10 mW/cm for 9 min with a total dose of 5.4 J/cm. The following anterior corneal HOAs: total corneal HOAs, trefoil, secondary trefoil, coma, secondary coma, secondary astigmatism and spherical aberrations were analysed using the Scheimpflug-Placido Sirius (CSO, Italy) corneal topographer at baseline and 12 months following treatment. Multivariate analysis was used to evaluate the independent effect of HOA subtypes on changes in uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA).
At one year post CXL, UDVA and CDVA were significantly improved, -0.13 ± 0.19 LogMAR (P = 0.0005) and -0.08 ± .0.11 LogMAR (P = 0.0003), respectively. The mean preoperative trefoil, secondary trefoil, secondary coma and secondary astigmatism were 0.95 ± 0.46; µm, 0.20 ± 0.11; µm, 0.29 ± 0.19; µm and 0.42 ± 0.17 µm, respectively. At one year, the mean values decreased significantly to 0.77 ± 0.47 µm, 0.15 ± 0.11 µm, 0.25 ± 0.18 µm and 0.34 ± 0.18 µm, respectively (P < 0.05, for all). No independent relationship between any HOA changes and change in UDVA was observed. A reduction in secondary coma aberration was associated with a change in CDVA (95% CI 0.01-1.34, P = 0.048; β = 0.67).
A 9-min protocol of Accelerated corneal cross-linking is an effective treatment in improving corneal HOAs at 12 months follow up, in eyes with progressive keratoconus at one year follow-up. A change in secondary coma had a statistically significant and independent effect on CDVA.
评估上皮下加速角膜交联(A-CXL)后角膜高阶像差(HOA)的变化,并探讨其对视力的影响。
本回顾性病例系列研究纳入 24 例 32 只眼圆锥角膜患者,均接受 A-CXL 治疗。治疗采用 10 mW/cm2 光强,共 9 分钟,总剂量为 5.4 J/cm2。使用 Scheimpflug-Placido Sirius(CSO,意大利)角膜地形图仪在基线和治疗后 12 个月时分析角膜前表面的高阶像差,包括总角膜像差、三叶像差、次三叶像差、彗差、次彗差、二次散光和球差。采用多变量分析评估各高阶像差亚组对未矫正远视力(UDVA)和矫正远视力(CDVA)变化的独立影响。
CXL 后 1 年,UDVA 和 CDVA 均显著提高,分别为-0.13±0.19 LogMAR(P=0.0005)和-0.08±0.11 LogMAR(P=0.0003)。术前三叶像差、次三叶像差、次彗差和次散光的平均值分别为 0.95±0.46、0.20±0.11、0.29±0.19 和 0.42±0.17 µm。治疗 1 年后,平均值分别显著降低至 0.77±0.47 µm、0.15±0.11 µm、0.25±0.18 µm 和 0.34±0.18 µm(P<0.05,均)。未观察到任何高阶像差变化与 UDVA 变化之间存在独立关系。次彗差像差的减少与 CDVA 的变化相关(95%CI 0.01-1.34,P=0.048;β=0.67)。
9 分钟的加速角膜交联方案在 12 个月随访时是一种有效的治疗方法,可改善进行性圆锥角膜患者 1 年随访时的角膜高阶像差。次彗差的变化对 CDVA 有统计学意义和独立的影响。